BRCA1 and BRCA2 and the genetics of breast and ovarian cancer.

By P. Welcsh, M. King. Human Molecular Genetics, 2001

677 citations recorded by the source corpus.

Subfields: Genetics, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/6e340a99e2aadd109683163766b2ca0857b05b91

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Genetics

1. S. West
2. M. King

In Molecular Biology

1. S. West
2. P. Jeggo
3. M. O’Driscoll

Citations in the corpus

• Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial. (2001, background): “This observation led to the suggestion that tamoxifen might be of use in reducing breast cancer risk among women with inherited mutations in the breast cancer predisposing genes BRCA1 or BRCA2.(2-5) Because the risk of breast cancer is much higher among women with BRCA1 or BRCA2 mutations compared w”
• Molecular views of recombination proteins and their control (2003, background): “People who carry mutations in BRCA1 or BRCA2 are predisposed to breast and/or ovarian cancer”